Suyash Prasad is CMO and Head of R&D of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 530,589 shares of TSHA, which is worth approximately $981,589. The most recent transaction as insider was on Jul 06, 2022, when has been sold 8,956 shares (Common Stock) at a price of $3.79 per share, resulting in proceeds of $33,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 531K
0% 3M change
0% 12M change
Total Value Held $981,589

SUYASH PRASAD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 06 2022
SELL
Open market or private sale
$33,943 $3.79 p/Share
8,956 Reduced 1.66%
530,589 Common Stock
Jul 05 2022
SELL
Open market or private sale
$13,707 $3.51 p/Share
3,905 Reduced 0.72%
539,545 Common Stock
Jul 01 2022
SELL
Open market or private sale
$84,448 $3.53 p/Share
23,923 Reduced 4.22%
543,450 Common Stock
Jun 30 2022
SELL
Open market or private sale
$51,678 $3.72 p/Share
13,892 Reduced 2.39%
567,373 Common Stock
Jun 29 2022
SELL
Open market or private sale
$46,954 $3.81 p/Share
12,324 Reduced 2.08%
581,265 Common Stock
Jul 01 2021
SELL
Open market or private sale
$416,191 $21.12 p/Share
19,706 Reduced 3.21%
593,589 Common Stock
Jun 30 2021
SELL
Open market or private sale
$452,112 $22.52 p/Share
20,076 Reduced 3.17%
613,295 Common Stock
Jun 29 2021
SELL
Open market or private sale
$959,272 $24.46 p/Share
39,218 Reduced 5.83%
633,371 Common Stock
Sep 28 2020
BUY
Conversion of derivative security
-
3,844 Added 0.57%
672,589 Common Stock
SP

Suyash Prasad

CMO and Head of R&D
Dallas, TX

Track Institutional and Insider Activities on TSHA

Follow Taysha Gene Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

News

Receive news related to Taysha Gene Therapies, Inc.

Track Activities on TSHA